Convalescent plasma for ebola virus disease

New England Journal of Medicine

Volumn 374, Issue 25, 2016, Pages 2498-2499

  Arribas, Jose R ^a   Luczkowiak, Joanna ^b   Delgado, Rafael ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b Universidad Complutense   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY AFFINITY; B LYMPHOCYTE; CELLULAR IMMUNITY; CONVALESCENT PLASMA; EBOLA VIRUS DISEASE; FILOVIRUS INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE ACTIVATION; IMMUNE RESPONSE; LETTER; MEDICAL LITERATURE; PLASMA; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; BLOOD COMPONENT THERAPY; FEMALE; HEMORRHAGIC FEVER, EBOLA; MALE; PREGNANCY;

BLOOD COMPONENT TRANSFUSION; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; PLASMA; PREGNANCY;

EID: 84975452180     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1602284     Document Type: Letter

References (3)

1. Van Griensven J, Edwards T, De Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 2016;374:33-42.
2. McElroy AK, Akondy RS, Davis CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015;112:4719-24.
3. Luczkowiak J, Arribas JR, Gómez S, et al. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Virus Res 2016;213:224-9.